Purpose The aim of the present study was to evaluate the effect of a porous silica-calcium
phosphate composite (SCPC50) loaded with and without recombinant human bone …

Objectives: Effective carrier technologies and dosing appear critical for the successful use of
bone morphogenetic proteins (BMPs). This study evaluated radiographically the potential of …

Recombinant human bone morphogenetic protein‐2 has been shown to promote bone
formation because of its osteoinductive property. The purpose of this study was to evaluate …

Aim: The objective of this study was to radiographically evaluate the potential of a purpose‐
designed titanium porous‐oxide implant surface coated with recombinant human bone …

Background: Studies using ectopic rodent, orthotopic canine, and non‐human primate
models show that bone morphogenetic proteins (BMPs) coated onto titanium surfaces …

Background: The objective of this study was to evaluate alveolar ridge augmentation
following surgical implantation of recombinant human bone morphogenetic protein‐2 …

This two-center human clinical trial evaluated recombinant human bone morphogenetic
protein-2 delivered in an absorbable collagen sponge (rhBMP-2/ACS) for either alvealar …

Background: Recombinant human bone morphogenetic protein‐2 (rhBMP‐2) in an
absorbable collagen sponge (ACS) carrier induces bone for reconstruction of skeletal …

Background: Recombinant human bone morphogenetic protein‐2 (rhBMP‐2) in an
absorbable collagen sponge (ACS) carrier has been shown to support significant bone …

Purpose: The main focused question of this systematic review was as follows: Does the
application of recombinant human bone morphogenetic protein-2 (rhBMP-2) placed in …